Top Markets
#1 Official Trump Official Trump +37.23%
#2 Movement Movement +23.31%
#3 EXOD EXOD +18.93%
#4 Mubarak Mubarak +18.79%
#5 Wrapped POL Wrapped POL +18.77%
#6 POL (ex-MATIC) POL (ex-MATIC) +18.22%
#7 Pearl Pearl +17.85%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.55%
#9 Melania Meme Melania Meme +16.90%
#10 Audiera Audiera +11.90%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Bonraybio Co., Ltd. Bonraybio Co., Ltd.

Bonraybio Co., Ltd.

6955
Rank in Stocks #23666
Bonraybio Co., Ltd., a Taiwanese biotechnology firm, specializes in pioneering... Bonraybio Co., Ltd., a Taiwanese biotechnology firm, specializes in pioneering automated medical diagnostic systems. Its flagship product family, LensHooke, centers on assessments for male reproductive health and fertility. By leveraging cutting-edge optical technology and artificial intelligence, they deliver swift, highly accurate semen analysis suitable for both professional clinical environments and convenient at-home diagnostics. Ultimately, Bonraybio strives to enhance both the accessibility and precision of infertility diagnostics through its array of portable and intuitive digital platforms.
Share Price
$3.59
Last synced: 2026-07-28
Market Cap
$70.60M
Change (1 day)
-1.74%
Change (1 year)
-34.83%
Country
TW
Trade Bonraybio Co., Ltd. (6955)

Category

Healthcare
Revenue for Bonraybio Co., Ltd. (6955)
Revenue in Aug 2026 TTM: 0
According to Bonraybio Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bonraybio Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH